Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Dyck

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 1, 1993
To screen or not to screenR F Dyck
Lancet (London, England)|November 24, 1979
Nephrotic syndrome and dermatitis herpetiformisR F Dyck
Clinical Biochemistry|December 1, 1988
C-reactive protein: a better indicator of complications other than acute rejection in renal allograft recipients?R F Dyck
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 15, 1994
Rates and outcomes of diabetic end-stage renal disease among registered native people in SaskatchewanR F Dyck, L Tan
BMJ (Clinical Research Ed.)|February 27, 1993
Gestational diabetes mellitusL Edouard, R F Dyck
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 26, 1998
Non-diabetic end-stage renal disease among Saskatchewan aboriginal peopleR F Dyck, L Tan
Transplantation Proceedings|April 1, 1989
The effect of cyclosporine A on the acute phase response in mice and humansR F Dyck, P S Owen
Clinical Nephrology|June 9, 1998
Impairment of methylamine clearance in uremic patients and its nephropathological implicationsP H Yu, R F Dyck
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 10, 2000
Renal transplantation in SaskatchewanM A Baltzan, R F Dyck
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1985
Fibronectin is an acute phase reactant in miceR F Dyck, S L Rogers
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 1, 1993
To screen or not to screenR F Dyck
Lancet (London, England)|November 24, 1979
Nephrotic syndrome and dermatitis herpetiformisR F Dyck
Clinical Biochemistry|December 1, 1988
C-reactive protein: a better indicator of complications other than acute rejection in renal allograft recipients?R F Dyck
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 15, 1994
Rates and outcomes of diabetic end-stage renal disease among registered native people in SaskatchewanR F Dyck, L Tan
BMJ (Clinical Research Ed.)|February 27, 1993
Gestational diabetes mellitusL Edouard, R F Dyck
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 26, 1998
Non-diabetic end-stage renal disease among Saskatchewan aboriginal peopleR F Dyck, L Tan
Transplantation Proceedings|April 1, 1989
The effect of cyclosporine A on the acute phase response in mice and humansR F Dyck, P S Owen
Clinical Nephrology|June 9, 1998
Impairment of methylamine clearance in uremic patients and its nephropathological implicationsP H Yu, R F Dyck
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 10, 2000
Renal transplantation in SaskatchewanM A Baltzan, R F Dyck
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1985
Fibronectin is an acute phase reactant in miceR F Dyck, S L Rogers
Pageof 5